Optigenex Stock

Optigenex EV/EBIT

EV/EBIT (Enterprise Value to EBIT) of Optigenex (OPGX) as of Aug 3, 2026.

EV/EBIT

-0.00

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Optigenex is 2026 -0.00 . EV/EBIT (Enterprise Value to EBIT) of Optigenex was 2025 - . It decreases by % lower compared to the previous year.

The Optigenex EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2004
0.00 base
Jan 1, 2005
0.00 base
Jan 1, 2006
0.00 base
Jan 1, 2007
0.00 base
Jan 1, 2009
0.00 base
Jan 1, 2010
0.00 base
YEARPRICE-TO-EBIT
2010 -
2009 -
2007 -
2006 -
2005 -
2004 -
Access this data via the Eulerpool API

Optigenex Valuation

Details

Historical Valuation Multiples

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Optigenex's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Optigenex's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Optigenex's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Optigenex grows earnings faster than its peers.

Optigenex Stock analysis

What does Optigenex do? Optigenex Inc. is a US-based company that operates in the health and beauty industry. It was founded in 2004 by a team of experienced entrepreneurs from the healthcare sector. The company's business model focuses on the development and marketing of innovative products based on science, research, and technological advancements. Optigenex has three main divisions: health, wellness, and beauty, each offering a variety of products tailored to meet the specific needs and requirements of consumers. The products offered by Optigenex include dietary supplements, anti-aging products, cosmetics, skincare products, hair products, and general health and well-being products. All products are manufactured in the USA and undergo strict quality controls. Optigenex has received numerous awards and recognition for its products and services in recent years, and it takes pride in being known for its unique products and high quality standards in the industry. The company also places a strong emphasis on research and development, collaborating closely with experts and research institutions to constantly develop new innovations and improved products. Optigenex has an extensive research and development department dedicated solely to the development of new technologies, products, and services. A key component of Optigenex's business model is its partner program, which offers partners the opportunity to market and earn money from its products. The company has developed an extensive training program for its partners to ensure they have all the necessary information and knowledge to build a successful business. Optigenex aims to become a global company that offers its products and services worldwide. The company already has a strong presence in the US and some European countries, and it intends to expand its reach and establish a foothold in other regions of the world in the future. Overall, Optigenex is a leading company in the health and beauty industry. With a wide range of innovative products, a strong focus on research and development, and a dedicated team of professionals and partners, the company strives to maintain and expand its position as a market leader in the industry. Optigenex is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Optigenex stock

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) Optigenex since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s Optigenex with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Optigenex

All Key Metrics — Optigenex